Claim being checked · Version 1 · Reviewed
“Ipamorelin stimulates GH release in people.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Supported with scope. The reviewed evidence supports this exact statement only in the situation described below.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for Ipamorelin.
01 · Answer
Supported with scope
A human dose-escalation study measured an episode of GH release. That is a pharmacodynamic effect.
- What kind of evidence this is
- Human pharmacology. This answer uses a study of how the substance enters or changes the body in people. This alone does not show a health benefit.
- What this answer covers
- Short-term GH pharmacodynamics in the healthy volunteers and route studied. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Mechanism and biomarkers. How a substance changed the body or a lab measurement. This may not show a health benefit.
02 · Sources
Read the sources behind this answer
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.